Other OTC - Delayed Quote USD

Better Therapeutics, Inc. (BTTX)

0.0100 +0.0010 (+11.11%)
At close: April 26 at 3:53 PM EDT
All All Favorites Text Statistics Technicals Fibonacci Markings Lines
Loading Chart for BTTX

Recent News: BTTX

View More
Better Therapeutics Announces it will Seek Strategic Alternatives and will be Delisted from Nasdaq

Better Therapeutics Announces it will Seek Strategic Alternatives and will be Delisted from Nasdaq
Business Wire last month
Better Therapeutics Announces an Innovative Partnership with the American College of Lifestyle Medicine to Expand Access to AspyreRx Across 1,400 Federally Qualified Health Centers

Better Therapeutics Announces an Innovative Partnership with the American College of Lifestyle Medicine to Expand Access to AspyreRx Across 1,400 Federally Qualified Health Centers
Business Wire last month
Better Therapeutics Announces Acceptance of Late Breaking Abstract for Its AspyreRx Pivotal Trial 180 Day Outcomes and Participation at the 17th International Conference on Advanced Technologies & Treatments for Diabetes (ATTD)

Better Therapeutics Announces Acceptance of Late Breaking Abstract for Its AspyreRx Pivotal Trial 180 Day Outcomes and Participation at the 17th International Conference on Advanced Technologies & Treatments for Diabetes (ATTD)
Business Wire last month
Better Therapeutics and Biotricity Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV

Better Therapeutics and Biotricity Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV
ACCESSWIRE last month
Better Therapeutics Receives FDA Breakthrough Device Designation for Digital Therapeutic Platform Targeting Advanced Liver Disease

Better Therapeutics Receives FDA Breakthrough Device Designation for Digital Therapeutic Platform Targeting Advanced Liver Disease
Business Wire 2 months ago
Better Therapeutics Signs Rebate Agreement with One of the Largest Pharmacy Benefit Managers in the US for its AspyreRx Diabetes Treatment

Better Therapeutics Signs Rebate Agreement with One of the Largest Pharmacy Benefit Managers in the US for its AspyreRx Diabetes Treatment
Business Wire 2 months ago
David Perry Bought 8.6% More Shares In Better Therapeutics

David Perry Bought 8.6% More Shares In Better Therapeutics
Simply Wall St. 3 months ago
Better Therapeutics Announces Publication of Cost-Effectiveness Analysis Demonstrating AspyreRx is More Effective and Less Costly than Standard of Care Alone

Better Therapeutics Announces Publication of Cost-Effectiveness Analysis Demonstrating AspyreRx is More Effective and Less Costly than Standard of Care Alone
Business Wire 3 months ago
Better Therapeutics and Glooko Announce Partnership to Accelerate Adoption of AspyreRx to Treat Type 2 Diabetes in the United States

Better Therapeutics and Glooko Announce Partnership to Accelerate Adoption of AspyreRx to Treat Type 2 Diabetes in the United States
Business Wire 3 months ago
Better Therapeutics Insiders Added US$6.57m Of Stock To Their Holdings

Better Therapeutics Insiders Added US$6.57m Of Stock To Their Holdings
Simply Wall St. 3 months ago
Better Therapeutics Announces Submission for FDA Breakthrough Device Designation for Digital Therapeutic Platform to Treat Liver Disease

Better Therapeutics Announces Submission for FDA Breakthrough Device Designation for Digital Therapeutic Platform to Treat Liver Disease
Business Wire 3 months ago
Better Therapeutics Strengthens Financial Position Through Amendment to Debt Facility and Implementation of Cost Reductions

Better Therapeutics Strengthens Financial Position Through Amendment to Debt Facility and Implementation of Cost Reductions
Business Wire 4 months ago
View More

Related Tickers

CLNN Clene Inc.
0.3399
-1.90%
 
BLPH Bellerophon Therapeutics, Inc.
0.0554
+0.73%
 
ZVSA ZyVersa Therapeutics, Inc.
4.9900
-16.83%
 
RNAZ TransCode Therapeutics, Inc.
0.5499
+5.30%
 
SNTI Senti Biosciences, Inc.
0.2900
+4.05%
 
BCEL Atreca, Inc.
0.0800
-6.43%
 
CLDI Calidi Biotherapeutics, Inc.
0.1607
+0.44%
 
PXMD PaxMedica, Inc.
0.7398
+5.06%
 
QNRX Quoin Pharmaceuticals, Ltd.
0.6375
+1.21%
 
KTRA Kintara Therapeutics, Inc.
0.1488
-5.82%